Pregabalin Orally Disintegrating Tablet 75 mg (Pregabalin)

Adult dosage

This medication should be administered orally as pregabalin, divided into twice daily doses regardless of meals, placing on the tongue and swallowing without water. 1. Neuropathic Pain - Peripheral Neuropathic Pain: starting dose 150 mg per day, titrate up to 300 mg per day after 3 to 7 days, further titration to maximum 600 mg every 7 days is possible. - Central Neuropathic Pain: starting dose 150 mg per day:

Children's dosage

Safety and efficacy data are insufficient for pediatric patients under 12 years of age and adolescents aged 12 to 17, hence administration is not recommended.

This medication may increase the risk of suicidal thoughts or behavior; therefore, patients should be monitored for mood changes or depressive symptoms during treatment and should consult a doctor immediately if these occur. Patients with hypersensitivity to this medication should not take it. Diabetic patients may experience weight gain while using this medication, thus possibly requiring dose adjustments of blood sugar-controlling medications. If swelling occurs around the face or mouth due to an allergic reaction, discontinue the medication immediately and inform healthcare personnel. Elderly patients should be cautious as dizziness or drowsiness may increase, increasing the risk of falls or injury while using this medication. Temporary blurred vision or changes in vision may occur; consult a doctor if these symptoms appear. Abrupt discontinuation of this medication may lead to withdrawal symptoms such as insomnia, anxiety, and headache, so a gradual tapering should be done under physician guidance. Patients with a history of substance abuse may have an increased risk of misuse of this medication and should be cautious while using it. Patients with impaired renal function may require dosage adjustments. Patients with serious heart disease should use this medication cautiously. Combining this medication with other central nervous system depressants or opioids may increase the risk of respiratory depression. Pregnant women should avoid using this medication during early pregnancy as it may affect the fetus, and should discuss with their physician before using it. Breastfeeding mothers should consider that this medication may be passed to the infant through breast milk, necessitating the consideration of either stopping breastfeeding or discontinuing the medication. Before engaging in hazardous activities such as driving or operating machinery, it is necessary to check whether this medication causes dizziness or drowsiness. Overdose may result in confusion, drowsiness, seizures, etc., therefore dosing should be strictly adhered to, and in case of overdose, immediate medical attention is necessary. Store out of reach of children, and do not transfer to other containers for safety.

Serious side effects

Hives, severe swelling, angioedema, chest tightness, difficulty breathing, cold sweats, pallor, high fever with severe rash, blisters, skin peeling, pain in oral/nasal mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory issues accompanied by cough and fever, jaundice (yellowing of the skin or eyes), extreme lethargy, sudden severe headache, thunderclap headache, seizures, confusion, vision disturbances

Mild side effects

• Dizziness
• drowsiness
• confusion
• disorientation
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

Store this medication in a tightly sealed container to protect it from air and moisture. The storage temperature should be maintained between 1 and 30 degrees Celsius, avoiding excessively hot or cold environments.

Appearance

Light orange diamond-shaped orally disintegrating tablet

Package unit

30 tablets/PTP [10 tablets/PTP x 3], 100 tablets/PTP [10 tablets/PTP x 10]